A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

about

A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

Item

http://www.wikidata.org/entity/Q48278642

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@en

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@nl

type

Item

label

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@en

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@nl

prefLabel

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@en

A randomized, double-blind, pl ...... perenne peptide immunotherapy.

@nl

P1476

A randomized, double-blind, pl ...... perenne peptide immunotherapy

@en

P2093

A Astvatsatourov

http://www.w3.org/2001/XMLSchema#string

E M Kasche

http://www.w3.org/2001/XMLSchema#string

G Zadoyan

http://www.w3.org/2001/XMLSchema#string

J Singh

http://www.w3.org/2001/XMLSchema#string

L Haazen

http://www.w3.org/2001/XMLSchema#string

L Sohlich

http://www.w3.org/2001/XMLSchema#string

R Mösges

http://www.w3.org/2001/XMLSchema#string

S Pirotton

http://www.w3.org/2001/XMLSchema#string

S R Durham

http://www.w3.org/2001/XMLSchema#string

T Legon

http://www.w3.org/2001/XMLSchema#string

P2860

Allergen injection immunotherapy for seasonal allergic rhinitis

T Cell Epitope Peptide Therapy for Allergic Diseases

Patterns of pollen cross-allergenicity.

Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medici

Exploratory study of tolerability and immunological effect of a short up-dosing immunotherapy phase with a standardised allergen extract derived from pollen of Olea europaea

Update on the current status of peptide immunotherapy.

Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients

Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.

Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.

P304

896-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.13358

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kija Shah-Hosseini

E Raskopf

M H Shamji

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29150857

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

placebo

P932

5947135

http://www.w3.org/2001/XMLSchema#string